Guidance Capital’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.83M Sell
12,313
-78
-0.6% -$10.8K 0.4% 45
2026
Q2
$1.58M Buy
12,391
+108
+0.9% +$12.6K 0.34% 62
2026
Q1
$1.39M Buy
+12,283
New +$1.42M 0.31% 74

Other funds holding MRK

Guidance Capital's MRK Position: Q3 2026 in Review

Guidance Capital reduced its Merck (MRK) stake by 0.63% in Q3 2026, selling an estimated $10.8K and leaving 12,313 shares worth $1.83M. The position accounts for 0.4% of the portfolio, ranked #45.

Guidance Capital first reported a position in MRK in Q1 2026 and has held it in 3 quarters since. 3,712 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Guidance Capital held 12,313 shares of Merck worth $1.83M as of Q3 2026.
  • Guidance Capital sold 78 Merck shares in Q3 2026, an estimated $10.8K.
  • Merck made up 0.4% of Guidance Capital's portfolio in Q3 2026, its #45 holding.
  • Guidance Capital first reported a position in Merck in Q1 2026 and has held it in 3 quarters since.
  • 3,712 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Guidance Capital's 13F filing for Q3 2026, filed 3 Nov 2026.